DUBLIN--(BUSINESS WIRE)--The "eClinical solutions Market By Product, By Delivery Mode, By Clinical Trial Phase, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.
The global eClinical solutions market was valued at $6,816.17 million in 2021, and is estimated to reach $21,502.95 million by 2031, growing at a CAGR of 12.2% from 2022 to 2031.
eClinical solutions are software, which are used for effective management, and integration of data generated during clinical trials. It offers set of tools to effectively plan, manage, track clinical study portfolio and create insights. The major factors that drive the growth of the eClinical solutions market are decrease in time cycle, reduction in data duplication, and additional efforts taken by teams carrying out clinical trials for sorting and integrating the data.
In addition, eClinical solutions accelerate decision making as data is sorted and integrated by the software itself. It is a key trend of the market, which is expected to fuel the growth of the market during the forecast period. These solutions creates the demographic charts, mapping and comprehensive analytics that answer clinical and operational questions with speed and accuracy. Thus by centralizing data issues, errors are identified sooner and decision making process gets accelerated.
Furthermore, a significant surge in technological advancement is also one leading factors of this market. Paperwork takes time, thus, managing enormous data makes individuals frustrated. By using advanced technological solutions it becomes easier to manage data for the team carrying out clinical trials.
Moreover, emerging markets are becoming a hub for the growth of eClinical solutions utilization owing to rise in the number of clinical trials. There are lot of opportunities for the market players to expand their business across developing economies due to availability of resources at lower rate and less regulatory policies for drug development.
Augmentation of data, government initiatives for making better healthcare services assists the market growth in emerging markets. However, eClinical solutions required high initial capital cost and regular maintenance attempts, which impede the market growth. The eClinical solutions market is segmented on the basis of product, delivery mode, clinical trials, end user, and region.
Key Market Segments
By Delivery Mode
- Web-hosted
- On-premise
- Cloud-based
By Clinical Trial Phase
- Phase I
- Phase II
- Phase III
- Phase IV
By Product
- Clinical Trial Management Systems
- Randomization and Trial Supply Management
- Electronic Clinical Outcome Assessment
- Electronic Trail Master Files
- Others
- Electronic Data Capture and Clinical Data Management Systems
By End User
- Pharmaceutical and Biopharmaceutical Companies
- Contract Research Organizations
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Advarra, Inc. (Bio Optronics, Inc.)
- Anju Software, Inc.
- Business Systems Integration AG
- Castor EDC
- Clario
- Dassault Systemes (Medidata Solution, Inc.)
- DataTrak International, Inc.
- eClinical Solutions, Inc.
- IBM Watson Health
- MaxisIT Inc.
- MedNet Solutions
- Medrio, Inc.
- Parexel International Corporation (Calyx)
- Saama Technologies, Inc.
- Signant Health (CRF Health Inc.)
- veeva systems
- Oracle Corporation
Key Topics Covered:
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: ECLINICAL SOLUTIONS MARKET, BY PRODUCT
CHAPTER 5: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE
CHAPTER 6: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE
CHAPTER 7: ECLINICAL SOLUTIONS MARKET, BY END USER
CHAPTER 8: ECLINICAL SOLUTIONS MARKET, BY REGION
CHAPTER 9: COMPANY LANDSCAPE
CHAPTER 10: COMPANY PROFILES
For more information about this report visit https://www.researchandmarkets.com/r/userrm
